ACHE and nervous system disorder: Amongst all the compounds tested, multi-target MTDL-3 particularly emerged as a ligand possessing a number of remarkable potential benefits for use in this neurological disorder including well-balanced dual AChE/MAO inhibition, strong metal-chelating activity, neuroprotective and anti-apoptotic properties, potent antioxidant capacities and anti-inflammatory action.